These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7378215)

  • 41. [Echocardiographic evaluation of the effect of prazosin in aortic insufficiency (author's transl)].
    Koudelková E; Jebavý P
    Cas Lek Cesk; 1980 Dec; 119(52):1436-40. PubMed ID: 7459975
    [No Abstract]   [Full Text] [Related]  

  • 42. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC; Feldman RC; Ball RM
    Cardiology; 1980; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract]   [Full Text] [Related]  

  • 44. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term vasodilator therapy in patients with severe aortic regurgitation.
    Evangelista A; Tornos P; Sambola A; Permanyer-Miralda G; Soler-Soler J
    N Engl J Med; 2005 Sep; 353(13):1342-9. PubMed ID: 16192479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
    Fitchett DH; Pathé M; Pardy R; Despas P
    Br Heart J; 1980 Aug; 44(2):215-20. PubMed ID: 7426176
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative study of vasodilator drugs in heart valve diseases].
    Lavítola Pde L; de Moraes AV; Dallan L; Grinberg M; Sosa EA; Higa SS; Bessegato L; Pileggi F
    Arq Bras Cardiol; 1987 Mar; 48(3):161-5. PubMed ID: 3314810
    [No Abstract]   [Full Text] [Related]  

  • 48. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemodynamic effects of prazosin.
    Oates HF; Graham RM; Stoker LM; Stokes GS
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):239-47. PubMed ID: 1015921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 51. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 52. [Efficacy of prazosin in severe cardiac insufficiency].
    Timio M; Gentili S; Schiaroli M; Ronconi M
    G Ital Cardiol; 1979; 9(12):1371-7. PubMed ID: 549785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of vasodilator therapy on mitral and aortic insufficiency in a Doppler echocardiography study].
    Kozáková M; Poch T
    Vnitr Lek; 1987 Apr; 33(4):324-31. PubMed ID: 3590630
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical, haemodynamic, and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease.
    Basta LL; Raines D; Najjar S; Kioschos JM
    Br Heart J; 1975 Feb; 37(2):150-7. PubMed ID: 804313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
    Lund-Johansen P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):107S-111S. PubMed ID: 583322
    [No Abstract]   [Full Text] [Related]  

  • 57. Can prazosin be used in the treatment of refractory heart failure only on the basis of clinical monitoring?
    Nikolić V; Planinc D; Rudar M; Pagon L
    Wien Med Wochenschr; 1987 Jan; 137(1):9-13. PubMed ID: 3590814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prazosin in the treatment of chronic cardiac insufficiency].
    Champoud O; Cribier A; Letac B
    Ann Med Interne (Paris); 1985; 136(3):261-5. PubMed ID: 2862824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differing effects of the vasodilator drugs, prazosin and diazoxide on plasma renin activity in the dog.
    Graham RM; Muir MR; Hayes JM
    Clin Exp Pharmacol Physiol; 1976; 3(2):173-7. PubMed ID: 975613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of a single oral dose of prazosin on venous reflex response, blood pressure and pulse rate in normal volunteers.
    Schapel GJ; Betts WH
    Br J Clin Pharmacol; 1981 Dec; 12(6):873-81. PubMed ID: 7340889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.